Head to head
Honeywell vs 3M
Side-by-side on the measures that matter, with a plain-English read. Full detail: HON · MMM
HON
Honeywell
212.64-2.39%
1-year price shape — +5% over the period
Quant Rating D · 44/100
vs
MMM
3M
177.99-0.27%
1-year price shape — +10% over the period
Quant Rating C · 51/100
1-year performance, rebased to 100
Honeywell edges it on the scoreable measures. Honeywell trades cheapest on trailing earnings; Honeywell pays the highest dividend yield; Honeywell earns the most per share.
| HON | MMM | |
|---|---|---|
| Snapshot | ||
| Sector | Conglomerates | -- |
| Last price | 212.64 | 177.99 |
| Change today | -2.39% | -0.27% |
| 1-year return | +4.9% | +9.7% |
| Market cap | $67.48B | $91.97B |
| 52-week range | 196.36 – 267.89 | 137.44 – 196.08 |
| Valuation | ||
| P/E (TTM) | 9.60 | 26.57 |
| P/E percentile, own 5-yr range | 6th | 83rd |
| P/B | 3.01 | 22.28 |
| Dividend yield | 3.69% | 1.72% |
| Profitability & growth | ||
| EPS (TTM) | 14.72 | 6.00 |
| Net profit (TTM) | $4.67B | $3.10B |
| Revenue (TTM) | $46.60B | $25.25B |
| Provider revenue period date | 2026-09-29 | 2026-09-29 |
| Revenue growth (YoY) | +1.3% | +1.0% |
| Gross margin | 37.2% | 39.5% |
| Operating margin | 18.6% | 20.1% |
| Net margin | 18.7% | 14.0% |
| Free cash flow (TTM) | $967.00M | $2.68B |
| Provider cash-flow period date | 2026-09-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 81.5% | 77.0% |
| Insider activity (12mo) | 26 buy / 18 sell | 24 buy / 22 sell |
| Short interest (% of float) | 2.1% | 1.9% |
| Analyst consensus | 44% buy / 56% hold (9) | 36% buy / 55% hold / 9% sell (11) |
| Analyst price target | $255 (+20%) | $198 (+11%) |
| StockVane view | ||
| StockVane Quant Rating | D (44) | C (51) |
| Company | ||
| Employees | 101,000 | 60,500 |
| Founded | 1985 | 1929 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.